ICE Bioscience Secures Series B+ Financing to Boost Integration Capabilities
Beijing-based Contract Research Organization (CRO) ICE Bioscience has reportedly raised close to RMB 100 million...
Sumitomo Pharma and Otsuka’s Ulotaront Fails to Meet Primary Endpoint in Schizophrenia Trials
Japan-based Sumitomo Pharma Co., Ltd (TYO: 4506) and Otsuka Pharmaceutical Co., Ltd (FRA: OS1) have...
Siemens Healthineers Reports 3.6% YOY Revenue Growth in Q3 2023 Financials
Germany-based life sciences giant Siemens Healthineers AG (ETR: SHL) has released its financial results for...
Biogen Inc. to Acquire Reata Pharmaceuticals in $7.3 Billion Deal
US-based Biogen Inc., (NASDAQ: BIIB) has announced that it has reached an agreement to fully...
Pfizer Inc. Reports Q2 2023 Revenues, Signals Shift Beyond COVID-19 Products
US pharmaceutical giant Pfizer Inc., (NYSE: PFE) has released its financial results for the second...
EQRx Inc. to be Acquired by Revolution Medicines in All-Stock Transaction
US-based EQRx Inc. (NASDAQ: EQRX) has revealed that a definitive agreement has been signed for...
GSK Partners with Zuellig Pharma for Vaccine Distribution and Cold-Chain Management in Asia-Pacific
GlaxoSmithKline (GSK; NYSE: GSK), a leading global vaccine manufacturer, has signed an agreement with Philippines-based...
Luye Pharma’s Parkinson’s Disease Treatment LY03003 Receives NMPA Review Acceptance
Luye Pharma Group (HKG: 2186) has announced that the National Medical Products Administration (NMPA) has...
Mabwell Bioscience Secures Licensing Deals for Denosumab Biosimilars in Egypt and Pakistan
China-based Mabwell (Shanghai) Bioscience Co., Ltd (SHA: 688062) has announced separate licensing and commercialization agreements...
GeneMind Biosciences Secures RMB 400 Million in Series C Financing to Expand Gene Testing
Shenzhen-based DNA sequencer specialist, GeneMind Biosciences Co., Ltd, has reportedly raised RMB 400 million in...
Guangzhou Wondfo Biotech Partners with Indonesia’s Kimia Farma in IVD Field
China-based Guangzhou Wondfo Biotech Co., Ltd (SHE: 300482) has entered into a partnership with Indonesia’s...
InxMed Partners with GeneQuantum Healthcare to Develop Innovative ADCs
China-based firm InxMed (Nanjing) Co., Ltd has announced a strategic partnership with compatriot firm GeneQuantum...
Sansure Biotech Partners with Indonesian Firm for Localized Molecular Diagnostic Production
China-based molecular diagnostics specialist Sansure Biotech Inc. (SHA: 688289) has announced a strategic partnership with...
Sinopharm Partners with Harbin Institute of Technology to Boost Biomedical Industry Innovation
China National Pharmaceutical Group Corporation (Sinopharm, HKG: 1099) has announced a strategic partnership with Harbin...
NK Celltech and RongCan Biotech Partner to Advance mRNA NK Cell Therapy and LNP Delivery System
Shanghai-based NK Celltech and RongCan Biotech have entered into a partnership agreement to establish a...
Abbisko Therapeutics Initiates Phase II Clinical Trial for Pimicotinib in Tendon Sheath Giant Cell Tumor
Shanghai-based biotech Abbisko Therapeutics Co., Ltd (HKG: 2256) has announced the dosing of the first...
CASI Pharmaceuticals Enters Assignment Agreement with Mundipharma for Folotyn Commercialization in China
US-based CASI Pharmaceuticals Inc., (NASDAQ: CASI) has announced the execution of an assignment agreement with...
Astellas Pharma’s Zolbetuximab BLA Accepted by China’s CDE for Gastric Cancer Treatment
Japan-based Astellas Pharma Inc. (TYO: 4503) has announced that the Center for Drug Evaluation (CDE)...
Shanghai Junshi Biosciences Partners with Zein Biotechnology for PCSK9 mAb Commercialization in China
China-based Shanghai Junshi Biosciences Co., Ltd (HKG: 1877; SHA: 688180) has announced a partnership with...
MSD’s Q2 2023 Earnings: Keytruda and Gardasil Drive Growth Amid COVID-19 Sales Decline
US-based major Merck, Sharp & Dohme Inc., (MSD; NYSE: MRK) has released its financial results...